DNA Testing: 2 Popular Methods and Their Features

Contents:

• How Anna Wojcicki Changed the World of Genetics with 23andMe
• A Brief Overview of Genetic Testing in the US: From Popularity to Stagnation
• The Current Situation on the Russian Genetic Testing Market
• How Genetic Testing Works
• Frequently Asked Questions
• Method One: Autosomal DNA Analysis to Determine Ethnicity
• The Haplogroup Method: The Relationship between DNA and Ethnicity
• Comparison genetic tests: “Atlas” and Genotek

How Anna Wojcicki Changed the World of Genetics with 23andMe

In the late 1990s, DNA testing technology began to rapidly develop in the United States. With the beginning of the 2000s, companies offering genetic testing services began to appear on the market. At the same time, medical DNA genetics was developing, with doctors using tests to identify patients' predispositions to hereditary diseases. By 2006, the ancestry testing market was already estimated at $60 million, and the number of tests performed had reached half a million. This trend reflects growing interest in genetic testing, which not only helps people discover their ancestry but also plays a vital role in medical practice, helping identify risks and prevent disease. 23andMe, founded in 2006 by Anne Wojcicki, an American entrepreneur and wife of Sergey Brin, the founder of Google, revolutionized genetic research. Initially funded by Brin, 23andMe pioneered autosomal DNA testing. This innovation opened up new possibilities for identifying distant relatives and comparing genetic populations, significantly simplifying the process of genetic analysis for a wider audience. The company began selling anonymized genetic data to its pharmaceutical clients, sparking debate about the ethics of this practice. Nevertheless, this business model proved effective: customers received affordable tests, pharmaceutical companies received valuable information, and Wojcicki herself generated a steady income.

The test initially cost $999, but by 2012, advances in technology had significantly reduced the price to $100. 23andMe was the first to offer combination tests that provided information on both ancestry and health, distinguishing it from competitors that focused on only one area. Technological innovations and the availability of tests allowed more people to learn about their genetic makeup and health, making genetic testing more popular and accessible.

In 2009, the Food and Drug Administration (FDA) began reviewing 23andMe's products. Regulators required the company to prove the accuracy and safety of the medical data it offered, citing concerns that users could make erroneous medical decisions based on test results. As a result, the FDA banned the sale of health-related tests in 2013, putting 23andMe in financial trouble. To restore its reputation and return to the market, Wojcicki established a research division that proved the value of 23andMe's data to the pharmaceutical industry. By 2015, the FDA reapproved the company's tests, allowing it to fully restore operations. Ancestry has emerged as a strong competitor to 23andMe in the ancestry testing space. Early in its journey, Ancestry partnered with the Mormon Church, offering its services free to its members. This partnership, along with the influence of investor Brandon Fugal, fueled Ancestry's rapid growth and establishment as a market leader in the mid-2010s. Ancestry continues to expand its services, offering users access to extensive databases and genealogical resources, making it a popular choice for those seeking to discover their ancestry.

Ancestry focuses on restoring family genealogy by building extensive databases of kinship relationships. This allows people to find lost relatives and restore their family trees, which in turn helps strengthen family ties and preserve historical memory. The platform plays an important role in modern society, helping people learn more about their roots and heritage. Ancestry also provides access to unique archives and resources, making the ancestry search process more accessible and effective.

A Brief Overview of Genetic Testing in the US: From Popularity to Stagnation

Since 2017, the genetic ancestry testing market in the US has seen significant growth. The number of tests performed increased from 1.5 million at the beginning of 2017 to 26 million by the end of 2018. This surge in testing volume is primarily driven by leading companies offering genetic predisposition and ancestry testing services. The increased interest in genetic testing is driven by a growing awareness of the importance of genetic information for health and family history. Such tests allow users to better understand their ancestry and learn about possible health risks, which makes them popular among a wide audience.

Ancestry, one of the leading Ancestry, one of the largest players in the genetic testing market, had conducted only 3 million tests since its inception through mid-2017. By the end of 2019, that number had increased to 14 million, and as of 2022, the company reports having data on over 18 million users. In the summer of 2020, investment firm Blackstone acquired Ancestry for an impressive $4.7 billion, reflecting the growing interest in genetic testing and the importance of genealogical research for users. 23andMe has also seen significant growth, increasing the number of tests conducted from 1.2 million in 2017 to 12 million today. The company's revenue for 2020 was $300 million. 23andMe is currently planning to go public, considering a merger with VG Acquisition Corp. This decision has drawn criticism from financial analysts, who have expressed doubts about the appropriateness of such a move.

In the second half of 2019 Over the past few years, there has been a decline in consumer interest in genetic testing. In January 2020, Ancestry laid off 6% of its workforce, while 23andMe reduced its workforce by 14%. 23andMe CEO Anna Wojcicki believes that the main factor behind this decline was user dissatisfaction, which arose in the wake of the Facebook scandal, which demonstrated how companies can use and sell users' personal data. This incident significantly impacted trust in services related to the analysis of genetic information.

Genetic testing companies are responding to the decline in interest in their services by exploring new avenues for growth. This includes expanding the range of medical services and selling anonymized data to pharmaceutical companies. These steps will help not only attract new customers but also optimize business models, which is important in a changing market.

Ancestry and Blackstone deny any intention to sell customer data, but many experts believe that these companies may follow 23andMe's example in the future. Potential access to their databases could open new avenues for drug development. This raises serious questions about the privacy and security of personal information, making the topic important for discussion in the context of current trends in genetic research and pharmaceuticals.

The Current Situation on the Russian Genetic Testing Market

The genetic testing market in Russia began to develop in the early 2010s and has been actively growing since then. The leading players in this market are the Russian companies Genotek and Atlas, which offer a variety of genetic testing services. These companies provide access to modern DNA analysis technologies, allowing Russians to obtain information about their hereditary diseases, risks, and body characteristics. With the development of technology and increasing interest in health and disease prevention, the genetic testing market in Russia continues to expand, offering new opportunities for diagnostics and personalized medicine.

Exporting genetic samples abroad for testing in international laboratories is a serious problem. According to current Russian legislation, the export of such samples without the appropriate permission from the Russian Ministry of Health is prohibited, which significantly limits citizens' access to foreign services. This creates barriers to obtaining high-quality diagnostics and participating in clinical trials conducted outside the country. With rapidly advancing genetic technologies, the need to simplify the sample collection process is becoming increasingly urgent. Genotek, founded in 2010 by graduates of the Mechanics and Mathematics Department of Moscow State University—Artem Elmuratov, Valery Ilyinsky, and Kirill Petrenko—has since achieved significant success. In 2013, Genotek reached a turnover of $1 million, marking a significant milestone in its development. In 2016, the company attracted $2 million in investment from prominent investors, including former head of the Russian presidential administration Alexander Voloshin. Genotek subsequently received additional investment from major players such as Pharmstandard Holding and Yandex. These achievements confirm the growing interest in biotechnology and genetic research and attest to the company's strong market prospects.

In 2017, Genotek found itself at the center of a scandal after its founder, Valery Ilyinsky, stated that only 16% of the genes of modern Russians are derived from indigenous Russians. This statement drew sharp criticism from Russian geneticists and became a catalyst for changing the company's approach to interpreting genetic data. As a result, Genotek has begun to more carefully analyze and present information about the genetic heritage of Russians, confirming the importance of accuracy in genetic research.

Ilyinsky reports that over the past five years, Genotek's revenue has increased annually by 2.5-3 times. In 2019, its legal entity revenue amounted to 150 million rubles, and net profit reached 40 million rubles. This growth underscores the business's success and stable market development.

Atlas was founded in 2013 by Sergey Musienko, Andrey Perfilyev, Artem Rudi, and Dmitry Osipenko. They raised approximately $8 million in investment, enabling the company to enter the European market in 2016. In 2017, the head office was moved to the UK, further expanding Atlas's international presence.

Atlas continues to grow rapidly but does not disclose its financial performance. According to its financial statements, the Russian division's revenue in 2020 amounted to 161 million rubles. At the same time, net profit was negative, amounting to minus 51 million rubles. Atlas CEO Sergey Musienko and Genotek CEO Valery Ilyinsky emphasized that precise data on the size of the Russian market for genetic ancestry tests is unavailable. Musienko noted that in the US, ancestry tests have become the primary driver of growth for the entire industry, while in Russia and Europe, there has been a shift in emphasis toward health-related tests. This difference in approaches to genetic testing may influence market development and consumer preferences in different regions. According to Ilyinsky, approximately 100,000 genetic tests were performed in Russia in 2020. Genotek, according to him, conducted more than half of all tests, purchasing a significant amount of reagents from Illumina, a recognized leader in the production of consumables for genetic testing. This demonstrates growing interest in genetic research in Russia and a high level of confidence in the quality of equipment and reagents offered by Illumina.

Musienko and Ilyinsky believe that demand for genetic testing in Russia will increase. They believe the Russian market is 2-3 years behind the European market, which, in turn, is 2-3 years behind the American market. Ilyinsky noted that genetic testing services will become more accessible and widespread, which will lead to increased interest from the public. Given global trends, genetic testing can be expected to take an important place in healthcare and personal medicine in Russia.

How Genetic Testing Works

Every person has unique DNA, which consists of 23 pairs of chromosomes. These chromosomes play a vital role in determining sex characteristics: women have two X chromosomes (XX), while men have one X and one Y chromosome (XY). The remaining 22 pairs of chromosomes, known as autosomes, are identical for both sexes. This makes them valuable for studying inherited traits and genetic diseases. Understanding the structure and function of chromosomes is important for developing diagnostic and treatment methods for many diseases, as they contain information necessary for the proper functioning of the body.

Chromosomes are made up of three billion base pairs: adenine (A), guanine (G), thymine (T), and cytosine (C). Interestingly, 99.9% of these sequences are identical in all people, highlighting the unity of human nature. Differences, known as polymorphisms, can have a significant impact on health and predisposition to various diseases. These genetic variations may explain why some people are more susceptible to certain diseases, while others are more resistant. Understanding these differences is important for developing personalized treatments and disease prevention.

Some polymorphisms are directly associated with specific diseases, making it easier to assess the risk of developing them. However, there are more complex situations where diseases develop as a result of the interaction of multiple polymorphisms. In such cases, assessing the likelihood of their occurrence becomes significantly more difficult. This underscores the importance of in-depth research into the genetic factors that influence health and the need for a personalized approach in medicine.

Genetic testing is an important tool in medicine, but it is important to keep in mind that it does not always provide accurate results. Research shows that errors can occur both during genotyping and in the interpretation of the obtained data. This is especially true for rare genetic diseases, where testing carries the risk of false positives, when the result may erroneously indicate the presence of the disease. Therefore, before undergoing genetic testing, it is important to consult with qualified specialists and consider the potential limitations of the method.

The testing process begins with the client receiving a specialized test kit, including a saliva collection container. After sending the sample to the lab, specialists analyze the DNA and generate the genetic code as a long string of characters. There are two main testing methods:

The first method is DNA sequencing, which provides complete information about the genetic material. The second method is genetic testing, which focuses on specific regions of DNA and helps identify disease predispositions or inherited traits. Both methods provide a deep understanding of genetic information and can be useful in a variety of fields, including health, genealogy, and personalized medicine.

• Sequencing is the complete decoding of DNA. In 2003, this procedure cost about $50 million, but today it is available for as little as $1,000.
• Genotyping is a more cost-effective option that studies only specific regions of DNA that are of interest to scientists.

These methods help deepen our understanding of human genetic diversity and predisposition, which opens new perspectives in the fields of medicine and genetics. Analysis of genetic information allows us to identify patterns that can be used to develop personalized treatments and disease prevention. Thus, research in this area not only expands our knowledge but also contributes to progress in personalized medicine.

Frequently Asked Questions

Genetic testing provides valuable information about health and predisposition to various diseases, but it also carries certain risks of error. Errors can occur at various stages of testing, from sample collection to interpretation of results. Potential risks include false positive and false negative results, which can lead to incorrect medical decisions. False positive results can cause unnecessary anxiety and additional testing, while false negative results can create a false sense of security.

Furthermore, the quality and accuracy of tests can vary depending on the technology and laboratories used. Misinterpretation of data by doctors or patients can also be a source of error. It is important that genetic test results be discussed with qualified professionals who can explain their meaning and possible implications.

Understanding the risks of errors in genetic testing can help people make more informed decisions about their health and approach to disease prevention.

Errors can occur at various stages, such as sample collection and data analysis. Therefore, it is crucial to use tests provided by reliable and trusted companies and to consult with qualified medical professionals. This will help minimize the likelihood of errors and ensure the accuracy of the results.

Method One: Autosomal DNA Analysis to Determine Ethnicity

Modern genetic tests use autosomal DNA analysis, which allows you to match your DNA samples with ethnic groups. If the test shows matches with samples identified as Russian, this may indicate that the client has Russian roots. This approach not only helps identify ethnic origin but also provides an opportunity to better understand ancestral ties and cultural roots. Genetic testing is becoming increasingly popular among people seeking to learn more about their ancestors and their influence on modern life.

If the company's database contains a significant number of samples, it can identify narrower groups, such as Irish people from County Carlow or Russians from the north. Ancestry's platform provides the most detailed breakdown by region and population, making it one of the leaders in genetic research. This allows users to obtain accurate and detailed information about their ancestry and ethnicity, facilitating a deeper understanding of family history and cultural heritage.

The accuracy of genetic analysis results depends significantly on the volume of available DNA samples. In developing countries, collecting genetic material faces significant challenges, leading to less effective testing for Black, Indian, and South Asian individuals. As a result, results for these groups may be less reliable than data obtained for Americans and Western Europeans. This highlights the need for improved DNA collection and analysis methods in resource-poor countries to increase the accuracy of genetic testing and ensure equal access to quality healthcare.

Some companies use DNA analysis to determine predisposition to certain personality traits, psychological characteristics, and athletic abilities. Researchers are actively searching for genetic markers associated with outstanding athletes and individuals with unique skills. Scientific research confirms that some genes may influence athletic endurance and cognitive abilities. However, it is important to consider that these genetic factors only predispose to certain achievements, and their expression depends on many external conditions and personal efforts.

Haplogroup Method: The Link Between DNA and Ethnicity

Haplogroup determination is an important tool for establishing the genetic link between DNA and ethnic identity. This process is based on the analysis of unique mutations that are passed down from generation to generation. The study of haplogroups provides a deeper understanding of the origins and migrations of peoples, as well as revealing historical connections between different ethnic groups. Understanding haplogroups can be useful for both scientific research and personal genealogy projects, helping people learn more about their roots and cultural heritage.

Through evolution, humans develop harmless mutations, known as polymorphisms, which are passed on by inheritance. By studying these mutations in conjunction with historical and archaeological data, geneticists can trace lineages stretching back into the distant past. This allows us not only to better understand the genetic heritage of humanity but also to determine how these mutations influenced the adaptation and survival of different populations. The study of polymorphisms also helps uncover the secrets of migrations and interactions between ancient cultures.

Haplogroups are groups of mutations that have their own subcategories, called subclades. For example, my haplogroup R1a arose approximately 23,000 years ago and includes the subclade R1a1a1b, which formed approximately 7,000 years ago. Haplogroups and their subclades are important elements of genetic genealogy, allowing us to trace the migrations and evolution of human populations over millennia. Studying these groups helps us understand the diversity of genetic heritage and its influence on modern populations. Two main types of testing are used to accurately determine haplogroups. The first method is mitochondrial DNA analysis, which allows us to determine maternal lineages and their genetic relationships. The second method is Y-chromosome analysis, designed to study paternal lineages. These tests help us explore genetic heritage and ancestry and can also be useful in genealogical research. The choice between these methods depends on the research goals and the interests of the user.

• Y-DNA test: analyzes inheritance only through the male line, is only available to men.
• Mitochondrial DNA (mtDNA) test: covers genetic mutations of all ancestors in the female line, and can be taken by both women and men. However, mtDNA haplogroups have a lower correlation with ethnic groups, which is explained by the fact that in most peoples, women more often moved to be with their husbands, and children inherited the ethnicity of their fathers.

Haplogroups are an important tool for studying ethnicity and historical migrations. For example, haplogroup R1a has a strong association with Slavic peoples. It is found in a significant proportion of Russians, Belarusians, Ukrainians, and Poles, as well as Czechs, Slovenes, and the Baltic peoples. Haplogroup analysis allows us not only to trace the genetic links between ethnic groups but also to deepen our understanding of their historical development and cultural interactions. Understanding haplogroups facilitates a more accurate study of the origins of peoples and can be useful in anthropological and historical research.

There are exceptions that challenge generally accepted models. Haplogroup R1a is found not only among Slavs, but also among the Kyrgyz, Tajiks, and Brahmins of northern India. Interestingly, the "Western European" haplogroup R1b is also found among the Bashkirs and peoples of Central Asia, as well as among tribes in Central Africa. These data highlight the complexity of genetic diversity and migration processes that influenced the formation of ethnic groups in different regions of the world. Analysis of such haplogroups helps better understand the historical connections between peoples and their cultural interactions.

Comparison of genetic tests: Atlas and Genotek

Today, genetic tests are becoming increasingly accessible and popular. Atlas and Genotek offer a wide range of services, including ancestry and health tests. The Atlas test, which covers aspects of ancestry, health, and predisposition, costs 30,000 rubles. At the same time, a similar test from the British branch costs 159 pounds, which is equivalent to approximately 16,670 rubles. For a more in-depth analysis, studies such as genome sequencing for 94,500 rubles and gut microbiota analysis for 14,500 rubles are available. Genetic tests provide a unique opportunity to obtain information about your health and predispositions, which makes them increasingly in demand among the population.

The process of receiving test results is quite simple. After receiving the kit, which contains a cotton swab for collecting a DNA sample, the results become available in your personal account on the website within a month. This allows users to easily track the status of their tests and receive results at a convenient time.

The "Atlas" test offers an in-depth analysis of haplogroups and allows you to compare your autosomal DNA with samples from different peoples. For example, my paternal haplogroup is R1a1a1b, which appeared about 7,000 years ago and is associated with Slavic and Baltic ethnic groups. This test helps you better understand your roots and ethnicity, and also provides an opportunity to connect with your ancestors and explore the historical diversity of the population.

My genetic analysis results revealed famous figures such as actor Tom Hanks and the 12th-century Norse-Scottish commander Somerled. They also belong to my haplogroup, highlighting interesting historical connections and genetic diversity. This discovery allows me to gain a deeper understanding of my roots and see how history has shaped the destinies of people related by the same haplogroup.

On my mother's side, my genetic results indicate that I belong to haplogroup J1b1a. People with this haplogroup made a significant contribution to the development of agriculture in Europe. This subclade is characteristic of Slavic countries and Scandinavia, highlighting the historical connection between these regions and their agricultural traditions.

The test results show that my ancestry can be characterized as follows:

Values ​​below 5% are considered insignificant, and among the groups mentioned were Norwegians and Slovaks. The test also revealed the presence of Neanderthal genes, but their level was 4% lower than the average value recorded by the company's clients.

The Atlas provides a unique opportunity to visualize ancestral migrations covering the period from 100,000 BC to 10,000 BC. This information allows us to gain a deeper understanding of human settlement processes and their adaptation to different climatic conditions. The study of such migrations opens new horizons in the study of human history and evolution, emphasizing the importance of geographical and cultural factors in the formation of modern peoples.

Company Genotek offers an Atlas data interpretation service for 3,000 rubles. The Health and Ancestry test, which provides valuable information about genetic predispositions, costs 27,959 rubles. Additional tests, such as "Family Planning" and "Abilities," are also available, each for 7,999 rubles. These services will help you gain a deeper understanding of your health and genetics, making them useful for planning your future.

According to Genotek, my genetic makeup is 100% Russian, indicating a significant distance from other ethnic groups in the genetic space.

Genotek examined my ancestors, pointing to their role as the first horse tamers, and also noted the Sintashta archaeological culture. According to Genotek data, migrations occurred about 25,000 years ago in the Siberian region. These studies highlight the importance of the Sintashta culture in human history and its influence on the development of cattle breeding and agriculture in ancient times.

Ten days after the analysis, Genotek found 24 distant relatives, their names and places of residence are indicated. Among them was a famous colleague.

Surprisingly, I have a common ancestor with Tutankhamun, who lived 32,000 years ago, as well as with the philosopher David Hume, who lived 23,000 years ago. These facts highlight the connections between different historical eras and the importance of genealogy in understanding our heritage. Each of us can discover surprising connections to great figures of the past, making history even more fascinating.

The health sections of the two companies differ significantly. Both companies identified a mutation associated with hemochromatosis, as well as the risks of lactose intolerance and low caffeine sensitivity. This data allows us to more accurately assess my health and take steps to improve it. Understanding genetic factors such as hemochromatosis can help prevent potential diseases associated with excess iron accumulation in the body. Also, information about lactose intolerance and low caffeine tolerance can influence dietary choices and the consumption of certain foods. The findings highlight the importance of genetic testing for personalized health and lifestyle choices.

The atlas identified a high risk of varicose veins, gallstones, and hypothyroidism, as well as a predisposition to vitamin D deficiency. These factors can significantly impact overall health and are important to consider when planning preventative measures and treatment. Regular screening and attention to vitamin D levels can help reduce the risk of these conditions.

Genotec identified numerous predispositions, including a risk of acne, nicotine addiction, and obesity. Three rare inherited diseases, citrullinemia and phenylketonuria, were also identified. This demonstrates the importance of genetic testing for understanding individual risks and disease prevention. Using such data can help develop personalized health and lifestyle strategies.

Genotec features a "Abilities and Personality" tab that provides information about a person's predisposition to analyzing text and numerical information, as well as their reaction speed and creativity. This feature helps users better understand their strengths and capabilities, which can be useful in various areas of life. Learn how your genetic makeup influences your cognitive abilities and personality traits, and use this information to grow personally and professionally.